Dirk Leysen

825 total citations
27 papers, 647 citations indexed

About

Dirk Leysen is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dirk Leysen has authored 27 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dirk Leysen's work include Pharmacogenetics and Drug Metabolism (4 papers), Glaucoma and retinal disorders (4 papers) and Hormonal and reproductive studies (3 papers). Dirk Leysen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Glaucoma and retinal disorders (4 papers) and Hormonal and reproductive studies (3 papers). Dirk Leysen collaborates with scholars based in Belgium, Netherlands and Austria. Dirk Leysen's co-authors include Karolien Castermans, Olivier Defert, B.W.M.M. Peeters, C.L.E. Broekkamp, R. M. Pinder, Arnaud Bourin, Ingeborg Stalmans, Sandro Boland, Evelien Vandewalle and Tine Van Bergen and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and Journal of Computational Chemistry.

In The Last Decade

Dirk Leysen

24 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Leysen Belgium 13 259 110 105 103 97 27 647
Marie‐Claude Carrière Canada 13 275 1.1× 143 1.3× 30 0.3× 50 0.5× 215 2.2× 14 927
Paul A. Mieyal United States 9 241 0.9× 31 0.3× 36 0.3× 23 0.2× 14 0.1× 10 460
Debra K. Breuer United States 5 213 0.8× 78 0.7× 57 0.5× 9 0.1× 29 0.3× 5 394
Nathalie Ouimet Canada 7 181 0.7× 92 0.8× 20 0.2× 16 0.2× 278 2.9× 7 755
David A. Neel United States 9 272 1.1× 13 0.1× 33 0.3× 28 0.3× 189 1.9× 12 479
Werner Skuballa Germany 16 262 1.0× 70 0.6× 13 0.1× 41 0.4× 356 3.7× 45 863
Hélène Jûteau Canada 13 346 1.3× 158 1.4× 21 0.2× 25 0.2× 654 6.7× 22 1.4k
Katharina Mertsch Germany 16 245 0.9× 21 0.2× 18 0.2× 16 0.2× 70 0.7× 22 760
Difei Wang China 14 452 1.7× 37 0.3× 16 0.2× 95 0.9× 153 1.6× 26 806
Christina M. Barrett United States 11 160 0.6× 82 0.7× 10 0.1× 82 0.8× 107 1.1× 16 445

Countries citing papers authored by Dirk Leysen

Since Specialization
Citations

This map shows the geographic impact of Dirk Leysen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Leysen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Leysen more than expected).

Fields of papers citing papers by Dirk Leysen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Leysen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Leysen. The network helps show where Dirk Leysen may publish in the future.

Co-authorship network of co-authors of Dirk Leysen

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Leysen. A scholar is included among the top collaborators of Dirk Leysen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Leysen. Dirk Leysen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Holvoet, Tom, Sarah Devriese, Karolien Castermans, et al.. (2017). Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor. Gastroenterology. 153(4). 1054–1067. 110 indexed citations
4.
Hollanders, Karen, Tine Van Bergen, Nadège Kindt, et al.. (2015). The Effect of AMA0428, a Novel and Potent ROCK Inhibitor, in a Model of Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 56(2). 1335–1348. 43 indexed citations
5.
Boland, Sandro, Jo Alen, Arnaud Bourin, et al.. (2014). Novel Roflumilast analogs as soft PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(18). 4594–4597. 30 indexed citations
6.
Boland, Sandro, Olivier Defert, Jo Alen, et al.. (2013). 3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6442–6446. 26 indexed citations
7.
Roumen, Luc, K. Pieterse, P.A.J. Hilbers, et al.. (2011). Application of a ligand‐based theoretical approach to derive conversion paths and ligand conformations in CYP11B2‐mediated aldosterone formation. Journal of Computational Chemistry. 32(11). 2441–2448. 2 indexed citations
8.
Velde, Sarah Van de, Tine Van Bergen, Evelien Vandewalle, et al.. (2011). Topical application of AMA0076, a locally acting rho kinase (ROCK) inhibitor, results in a robust IOP control in a hypertensive rabbit model. Acta Ophthalmologica. 89(s248). 0–0. 1 indexed citations
9.
Roumen, Luc, Marijn P. A. Sanders, K. Pieterse, et al.. (2007). Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics. Journal of Computer-Aided Molecular Design. 21(8). 455–471. 47 indexed citations
10.
Gooyer, Marcel E. de, et al.. (2003). Tibolone is not converted by human aromatase to 7α-methyl-17α-ethynylestradiol (7α-MEE):. Steroids. 68(3). 235–243. 47 indexed citations
11.
12.
Vos, Filip De, H. Vermeirsch, G. De Ley, et al.. (2001). In vivo evaluation of 4-[123I]iodo-N-{2-[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl}benzamide, a potential SPECT radioligand for the 5-HT1A receptor. Nuclear Medicine and Biology. 28(6). 639–643. 10 indexed citations
13.
Bursi, Roberta, et al.. (2001). (Q) SAR study on the metabolic stability of steroidal androgens. Journal of Molecular Graphics and Modelling. 19(6). 552–556. 12 indexed citations
14.
Vos, Filip De, H. Vermeirsch, Koen Strijckmans, et al.. (2001). Synthesis and in vivo evaluation of [18F]ORG 13063, a potential pet radioligand for the 5‐HT1A receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 2 indexed citations
15.
Verdonk, Marcel L., J. A. Kanters, J. Kroon, et al.. (1997). Structure and Serotonin 5-HT2C Receptor Activity of ortho- and meta-Substituted Phenylpiperazines. Acta Crystallographica Section B Structural Science. 53(6). 976–983. 7 indexed citations
16.
Leysen, Dirk, Joannes T. M. Linders, & H. C. J. OTTENHEIJM. (1997). ChemInform Abstract: 5‐HT2 Antagonists: A Concept for the Treatment of Schizophrenia. ChemInform. 28(52). 2 indexed citations
17.
Broekkamp, C.L.E., Dirk Leysen, B.W.M.M. Peeters, & R. M. Pinder. (1995). Prospects for Improved Antidepressants. Journal of Medicinal Chemistry. 38(23). 4615–4633. 75 indexed citations
18.
19.
Wieringa, Joop H., et al.. (1993). Monoamine re‐uptake inhibiting 1‐[2‐[(phenoxyphenyl)methoxy]ethyl]‐ piperazines as potential antidepressants. Recueil des Travaux Chimiques des Pays-Bas. 112(2). 143–150. 2 indexed citations
20.
Zhang, Ming‐Qiang, et al.. (1992). Novel stereoselective calcium channel ligands of the diphenylalkylamine-type. Bioorganic & Medicinal Chemistry Letters. 2(10). 1283–1288. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Claude Carrière Breakdown of academic impact, for papers by Paul A. Mieyal Breakdown of academic impact, for papers by Debra K. Breuer Breakdown of academic impact, for papers by Nathalie Ouimet Breakdown of academic impact, for papers by David A. Neel Breakdown of academic impact, for papers by Werner Skuballa Breakdown of academic impact, for papers by Hélène Jûteau Breakdown of academic impact, for papers by Katharina Mertsch Breakdown of academic impact, for papers by Difei Wang Breakdown of academic impact, for papers by Christina M. Barrett
Rankless by CCL
2026